Kelly Morrison sold Johnson & Johnson (NYSE: JNJ)
Kelly Morrison (D-MN), a U.S. Representative, has disclosed 1 trade in Johnson & Johnson (JNJ) since 2025, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Kelly Morrison sold $1,001 - $15,000 of Johnson & Johnson (NYSE: JNJ) on August 19, 2025. Since that trade, JNJ is up +47.49% against the S&P 500 up +16.91%, an outperformance of +30.58%.
Data updated
Kelly Morrison's JNJ trades vs the price
JNJ is up +47.49% since Kelly Morrison sold on August 19, 2025, versus +16.91% for the S&P 500.
Performance since this trade
All Kelly Morrison JNJ trades
Kelly Morrison & JNJ trading FAQ
Is it legal for Kelly Morrison to trade Johnson & Johnson (JNJ) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Johnson & Johnson (JNJ), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Kelly Morrison sell JNJ?
Kelly Morrison disclosed a sale of $1,001 - $15,000 of Johnson & Johnson (JNJ) on August 19, 2025, according to public STOCK Act filings.
How has JNJ performed since Kelly Morrison's trade?
Since Kelly Morrison sold JNJ on August 19, 2025, the stock is up +47.49%, versus +16.91% for the S&P 500 over the same period, an outperformance of +30.58%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional JNJ trades?
Quantellect tracks every disclosed congressional trade in Johnson & Johnson (JNJ) on the Johnson & Johnson congressional trading page, which aggregates filings across all members of Congress.
Kelly Morrison's JNJ tradesAll congressional filings for Johnson & JohnsonKelly Morrison's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.